MedPath

Evaluation of the Efficacy of Ambu® aScope for Intubation in Cancer Tongue

Not Applicable
Completed
Conditions
Difficult Intubation
Interventions
Device: ambu ascope
Device: fibreroptic bronchoscope
Registration Number
NCT03999476
Lead Sponsor
mahmoud salem soliman
Brief Summary

This study compares the ascope with standard fiberscope using the nasal route of intubation in patient having sever difficult airway (having posterior one third cancer tongue with fixed mobility)

Detailed Description

patient will be allocated into two group according to the type of endoscope used group (F) fibro scope group and group (A) the ambu ascope group The timer will be started (T0), when touching the fiberscope or a scope. The standard fiberscope or a scope2 will be introduced through the nostril and advanced through the vocal cords, once carina identified the time will be recorded ( T1) When correct positioning of the trachea confirmed by detection of the end-tidal co2 curve on capnography (T2).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Adult patients of ASA physical status I and II who will be scheduled for posterior third fixed cancer tongue with severe difficult airway requiring naso-tracheal intubation
  2. aged 18-70 years
Exclusion Criteria
  1. ASA 2 or 4
  2. pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ambu scopeambu ascopeintubation of cancer tongue patients with ambu scope device
fiberopticfibreroptic bronchoscopeintubation of cancer tongue patients with fiberoptic device
Primary Outcome Measures
NameTimeMethod
time of successful intubation5 minutes

measuring time in seconds for reaching carina and time for successful intubation

.

Secondary Outcome Measures
NameTimeMethod
quality of vision5 minutes

subjective assessment by operator

easiness of intubation5 minutes

subjective assessment

number of intubation trials30 minutes

counting number of intubation in each group

incidence of complications15 minutes

accounting number of desaturation , bleeding , hypoxia .

Trial Locations

Locations (1)

Kasr Alini Univeristy Hospital

🇪🇬

Cairo, Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath